Table 3.
Effects of HMB on short-chain fatty acids (SCFAs) in jejunal and ileal contents of Tibetan lambs (n = 6)
| Items | Treatments1 | SEM | P-value | |||
|---|---|---|---|---|---|---|
| CON | L-HMB | M-HMB | H-HMB | |||
| Jejunum | ||||||
| Total SCFAs, mmol/L | 7.22b | 7.89b | 8.98a | 7.70b | 0.184 | < 0.001 |
| Acetate, mmol/L | 5.81b | 6.40b | 7.16a | 6.13b | 0.169 | 0.007 |
| Propionate, mmol/L | 0.71d | 0.83c | 1.14a | 0.94b | 0.035 | < 0.001 |
| Butyrate, mmol/L | 0.60 | 0.57 | 0.59 | 0.53 | 0.018 | 0.552 |
| Valerate, mmol/L | 0.10 | 0.09 | 0.09 | 0.10 | 0.006 | 0.704 |
| Acetate/Propionate | 8.26a | 7.82ab | 6.33b | 6.55b | 0.267 | 0.032 |
| Acetate, % | 80.44 | 80.93 | 79.51 | 79.49 | 0.482 | 0.774 |
| Propionate, % | 9.84b | 10.63ab | 12.87a | 12.29a | 0.393 | 0.031 |
| Butyrate, % | 8.30 | 7.27 | 6.55 | 6.84 | 0.266 | 0.082 |
| Valerate, % | 1.43 | 1.17 | 1.07 | 1.38 | 0.090 | 0.332 |
| Ileum | ||||||
| Total SCFAs, mmol/L | 12.82b | 13.94b | 16.04a | 14.03b | 0.318 | < 0.001 |
| Acetate, mmol/L | 9.83b | 11.04b | 12.66a | 11.07b | 0.285 | < 0.001 |
| Propionate, mmol/L | 1.49b | 1.51b | 1.89a | 1.47b | 0.043 | < 0.001 |
| Butyrate, mmol/L | 1.36 | 1.26 | 1.36 | 1.38 | 0.020 | 0.12 |
| Valerate, mmol/L | 0.13 | 0.13 | 0.13 | 0.12 | 0.001 | 0.17 |
| Acetate/Propionate | 6.58 | 7.32 | 6.72 | 7.59 | 0.170 | 0.10 |
| Acetate, % | 76.63b | 79.05a | 78.85a | 78.86a | 0.360 | 0.04 |
| Propionate, % | 11.70 | 10.94 | 11.81 | 10.46 | 0.222 | 0.089 |
| Butyrate, % | 10.65a | 9.09bc | 8.52c | 9.81ab | 0.217 | < 0.001 |
| Valerate, % | 1.01a | 0.91b | 0.82c | 0.87bc | 0.020 | < 0.001 |
SCFAs Short chain fatty acids
1HMB was supplemented at 0 mg/kg (CON group), 430 mg/kg (L-HMB), 715 mg/kg (M-HMB), and 1,000 mg/kg (H-HMB) of diet
a−dDifferent letters represent significant differences (P < 0.05)